Literature DB >> 18368600

Bovine dialyzable leukocyte extract modulates AP-1 DNA-binding activity and nuclear transcription factor expression in MCF-7 breast cancer cells.

E Mendoza-Gamboa1, M A Franco-Molina, P Zapata-Benavides, P Castillo-Tello, M E Vera-García, R S Tamez-Guerra, C Rodríguez-Padilla.   

Abstract

BACKGROUND: We have previously demonstrated that bovine dialyzable leukocyte extract (bDLE) induces death through an apoptosis mechanism in MCF-7 breast cancer cells. Depending on the cell type and stimulus, activating protein-1 (AP-1) has been shown to regulate cell proliferation and differentiation, the stress response, apoptosis and survival. It remains unknown whether AP-1 and other transcription factors are mechanisms by which bDLE induces cell death.
METHODS: To determine whether bDLE modulates the AP-1 DNA binding and gene expression, MCF-7 breast cancer cells were treated with bDLE (0, 1, 5, 10 U) for 72 h and evaluated by electrophoretic mobility shift assay, reverse transcriptase-polymerase chain reaction and Western blot assays.
RESULTS: bDLE induced inhibition of cell growth, suppressed the AP-1 DNA-binding activity, decreased c-Jun protein expression and modulated NFATx, NFATc, NFkappaB, c-Jun and c-Fos transcription factor gene expression in MCF-7 breast cancer cells. DISCUSSION: The present data indicate that bDLE can block the AP-1 DNA-binding activity and expression of several transcriptions factors in breast cancer cells, which will have great potential in improving cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18368600     DOI: 10.1080/14653240801891659

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  8 in total

1.  Clinical and immunological assessment in breast cancer patients receiving anticancer therapy and bovine dialyzable leukocyte extract as an adjuvant.

Authors:  Humberto H Lara; Liliana Ixtepan Turrent; Elsa N Garza-Treviño; Reyes Tamez-Guerra; Cristina Rodriguez-Padilla
Journal:  Exp Ther Med       Date:  2010-05-01       Impact factor: 2.447

2.  Antiviral mode of action of bovine dialyzable leukocyte extract against human immunodeficiency virus type 1 infection.

Authors:  Humberto H Lara; Liliana Ixtepan-Turrent; Elsa N Garza-Treviño; Jose I Badillo-Almaraz; Cristina Rodriguez-Padilla
Journal:  BMC Res Notes       Date:  2011-11-01

3.  Effect of bovine dialyzable leukocyte extract on induction of cell differentiation and death in K562 human chronic myelogenous leukemia cells.

Authors:  Crystel A Sierra-Rivera; Moisés A Franco-Molina; Edgar Mendoza-Gamboa; Pablo Zapata-Benavides; Jesús Santaolalla-Tapia; Erika E Coronado-Cerda; Reyes S Tamez-Guerra; Cristina Rodríguez-Padilla
Journal:  Oncol Lett       Date:  2016-10-18       Impact factor: 2.967

4.  IMMUNEPOTENT CRP induces cell cycle arrest and caspase-independent regulated cell death in HeLa cells through reactive oxygen species production.

Authors:  Ana Carolina Martínez-Torres; Alejandra Reyes-Ruiz; Milena Benítez-Londoño; Moises Armides Franco-Molina; Cristina Rodríguez-Padilla
Journal:  BMC Cancer       Date:  2018-01-03       Impact factor: 4.430

5.  The novel immunomodulator IMMUNEPOTENT CRP combined with chemotherapy agent increased the rate of immunogenic cell death and prevented melanoma growth.

Authors:  Maria Del Carmen Rodríguez-Salazar; Moises Armides Franco-Molina; Edgar Mendoza-Gamboa; Ana Carolina Martínez-Torres; Pablo Zapata-Benavides; Jose Sullivan López-González; Erika Evangelina Coronado-Cerda; Juan Manuel Alcocer-González; Reyes Silvestre Tamez-Guerra; Cristina Rodríguez-Padilla
Journal:  Oncol Lett       Date:  2017-05-18       Impact factor: 2.967

6.  Anti-Inflammatory Effect of Dialyzable Leukocyte Extract in Autoimmune Prostatitis: Evaluation in Animal Model.

Authors:  Carlos Pérez-Alvarado; Consuelo Gómez; Miguel Reyes; Mario García; Elizabeth Pérez; Carlos Pérez de la Mora; Virginia Sanchez; D Guillermo Pérez Ishiwara
Journal:  Biomed Res Int       Date:  2017-03-12       Impact factor: 3.411

7.  IMMUNEPOTENT CRP induces DAMPS release and ROS-dependent autophagosome formation in HeLa and MCF-7 cells.

Authors:  Ana Carolina Martínez-Torres; Alejandra Reyes-Ruiz; Kenny Misael Calvillo-Rodriguez; Karla Maria Alvarez-Valadez; Ashanti C Uscanga-Palomeque; Reyes S Tamez-Guerra; Cristina Rodríguez-Padilla
Journal:  BMC Cancer       Date:  2020-07-13       Impact factor: 4.430

8.  Cytotoxic activity of IMMUNEPOTENT CRP against non-small cell lung cancer cell lines.

Authors:  Luis Gomez-Morales; Alan B Martinez-Loria; Ana Carolina Martinez-Torres; Ashanti Concepcion Uscanga-Palomeque; Jose Manuel Vazquez-Guillen; Cristina Rodriguez-Padilla
Journal:  PeerJ       Date:  2019-09-27       Impact factor: 2.984

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.